{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:45:31Z","timestamp":1794051931935,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.expneurol.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T16:51:48Z","timestamp":1413132708000},"page":"122-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Application of neurophysiological biomarkers for Huntington's disease: Evaluating a phosphodiesterase 9A inhibitor"],"prefix":"10.1016","volume":"263","author":[{"given":"D\u00e1vid","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Francis D.","family":"Tingley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Stoiljkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-8576","authenticated-orcid":false,"given":"Mih\u00e1ly","family":"Haj\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.expneurol.2014.10.001_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainresbull.2010.04.008","article-title":"Mouse behavioral endophenotypes for schizophrenia","volume":"83","author":"Amann","year":"2010","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.expneurol.2014.10.001_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpsycho.2012.11.008","article-title":"Dysfunctional and compensatory duality in mild cognitive impairment during a continuous recognition memory task","volume":"87","author":"Aurtenetxe","year":"2013","journal-title":"Int. J. Psychophysiol."},{"issue":"2","key":"10.1016\/j.expneurol.2014.10.001_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clinph.2012.10.007","article-title":"Mapping repetition suppression of the P50 evoked response to the human cerebral cortex","volume":"124","author":"Boutros","year":"2013","journal-title":"Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.expneurol.2014.10.001_bb9000","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2014.10.001_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2014.10.001_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2012.11.011","article-title":"Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases","volume":"55","author":"Chaturvedi","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2014.10.001_bb0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.expneurol.2014.10.001_bb0040","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm040889k","article-title":"Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists","volume":"48","author":"Di Stefano","year":"2005","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.expneurol.2014.10.001_bb0045","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2014.10.001_bb0050","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/awt132","article-title":"Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mouse model of Huntington's disease","volume":"136","author":"Fisher","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.10.001_bb0055","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2007"},{"issue":"12","key":"10.1016\/j.expneurol.2014.10.001_bb0060","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating \u03b3 oscillations and delayed auditory responses as translational biomarkers of autism","volume":"68","author":"Gandal","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.expneurol.2014.10.001_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tips.2006.05.005","article-title":"Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery","volume":"27","author":"Haj\u00f3s","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2014.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/jpet.104.076968","article-title":"The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats","volume":"312","author":"Haj\u00f3s","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.expneurol.2014.10.001_bb0075","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2007.12.005","article-title":"Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia","volume":"63","author":"Haj\u00f3s","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2014.10.001_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2013.06.020","article-title":"Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors","volume":"75C","author":"Harvey","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0085","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.expneurol.2014.10.001_bb0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/archpsyc.65.9.1008","article-title":"Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate","volume":"65","author":"Hong","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.expneurol.2014.10.001_bb0095","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1162\/jocn_a_00356","article-title":"The impact of neurodegeneration on network connectivity: a study of change detection in frontotemporal dementia","volume":"25","author":"Hughes","year":"2013","journal-title":"J. Cogn. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuropharm.2011.05.009","volume":"61","author":"Hutson","year":"2011","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.expneurol.2014.10.001_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2463","article-title":"Neurophysiological biomarkers for drug development in schizophrenia","volume":"7","author":"Javitt","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.expneurol.2014.10.001_bb0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S1461145711000848","article-title":"Acute administration of typical and atypical antipsychotics reduces EEG \u03b3 power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in \u03b3 power","volume":"15","author":"Jones","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Pt 7","key":"10.1016\/j.expneurol.2014.10.001_bb0115","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/brain\/awt128","article-title":"Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation","volume":"136","author":"Kantor","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.10.001_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroscience.2013.01.058","article-title":"Rhythmic theta and delta activity of cortical and hippocampal neuronal networks in genetically or pharmacologically induced N-methyl-D-aspartate receptor hypofunction under urethane anesthesia","volume":"237","author":"Kiss","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.expneurol.2014.10.001_bb0125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/jpet.111.191353","article-title":"Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo","volume":"341","author":"Kleiman","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.expneurol.2014.10.001_bb0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2005.04.006","article-title":"Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect","volume":"28","author":"Llin\u00e1s","year":"2005","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.expneurol.2014.10.001_bb0135","doi-asserted-by":"crossref","first-page":"e69993","DOI":"10.1371\/journal.pone.0069993","article-title":"The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep","volume":"8","author":"Loh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2014.10.001_bb9005","article-title":"Effect of the rd1 mutation on motor performance in R6\/2 and wild type mice","author":"Menalled","year":"2012","journal-title":"Version 2. PLoS 4:RRN1303"},{"issue":"3","key":"10.1016\/j.expneurol.2014.10.001_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0145","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbrc.2008.01.017","article-title":"cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes","volume":"367","author":"Mitsuishi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00422-002-0373-7","article-title":"Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus","volume":"88","author":"Moxon","year":"2003","journal-title":"Biol. Cybern."},{"key":"10.1016\/j.expneurol.2014.10.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2013_250","article-title":"Therapeutic strategies for Huntington's disease","author":"Mrzljak","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2014.10.001_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainresrev.2010.03.004","article-title":"Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions","volume":"64","author":"Nguyen","year":"2010","journal-title":"Brain Res. Rev."},{"issue":"7113","key":"10.1016\/j.expneurol.2014.10.001_bb0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.10.001_bb0170","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.expneurol.2014.10.001_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-459-3_1","article-title":"NO\/cGMP: the past, the present, and the future","volume":"1020","author":"Russwurm","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.expneurol.2014.10.001_bb0180","doi-asserted-by":"crossref","first-page":"e73664","DOI":"10.1371\/journal.pone.0073664","article-title":"Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease","volume":"8","author":"Saavedra","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.expneurol.2014.10.001_bb0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.expneurol.2014.10.001_bb0190","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1476-5381.2012.02107.x","article-title":"First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors","volume":"167","author":"Schulz","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.expneurol.2014.10.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.12.010","article-title":"Age-dependent disruption in hippocampal \u03b8 oscillation in amyloid-\u03b2 overproducing transgenic mice","volume":"33","author":"Scott","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0200","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neuroscience.2005.10.029","article-title":"Grouping of brain rhythms in corticothalamic systems","volume":"137","author":"Steriade","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.expneurol.2014.10.001_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0893-133X(95)00178-G","article-title":"Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains","volume":"15","author":"Stevens","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0210","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/schbul\/sbn049","article-title":"Neurophysiological endophenotypes across bipolar and schizophrenia psychosis","volume":"34","author":"Thaker","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.expneurol.2014.10.001_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.baga.2013.08.001","article-title":"Modulation of striatal neuron activity by cyclic nucleotide signalling and phosphodiesterase inhibition","volume":"3","author":"Threlfell","year":"2013","journal-title":"Basal Ganglia"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2014.10.001_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(03)00082-0","article-title":"The midlatency auditory evoked potential P50 is abnormal in Huntington's disease","volume":"212","author":"Uc","year":"2003","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2014.10.001_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pbiomolbio.2010.10.004","article-title":"A new look at gamma? High- (>60Hz) \u03b3-band activity in cortical networks: function, mechanisms and impairment","volume":"105","author":"Uhlhaas","year":"2011","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"4","key":"10.1016\/j.expneurol.2014.10.001_bb0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/01677063.2011.630494","article-title":"The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task","volume":"25","author":"Vardigan","year":"2011","journal-title":"J. Neurogenet."},{"issue":"6","key":"10.1016\/j.expneurol.2014.10.001_bb0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2014.10.001_bb0240","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.113.208017","article-title":"cGMP-Selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury","volume":"347","author":"Whitaker","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.expneurol.2014.10.001_bb0250","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2012.02.015","article-title":"Disrupted GABAAR trafficking and synaptic inhibition in a mouse model of Huntington's disease","volume":"46","author":"Yuen","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"44","key":"10.1016\/j.expneurol.2014.10.001_bb0245","doi-asserted-by":"crossref","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","article-title":"A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease","volume":"32","author":"Yu-Taeger","year":"2012","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614003379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614003379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:14:54Z","timestamp":1772100894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488614003379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":52,"alternative-id":["S0014488614003379"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.10.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of neurophysiological biomarkers for Huntington's disease: Evaluating a phosphodiesterase 9A inhibitor","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}